| Literature DB >> 35798525 |
Bishav Mohan1, Bhupinder Singh1, Kavita Singh2,3, Nitish Naik4, Ambuj Roy4, Abhishek Goyal1, Gurbhej SIngh1, Shivaansh Aggarwal1, Aftabh Saini1, Rohit Tandon1, Shibba Takkar Chhabra1, Naved Aslam1, Gurpreet Singh Wander1, Dorairaj Prabhakaran5.
Abstract
OBJECTIVE: The COVID-19 pandemic necessitated the use of telemedicine to maintain continuity of care for patients with cardiovascular diseases (CVDs). This study aimed to demonstrate the feasibility of implementing a nurse-led teleconsultation strategy for CVD management during the COVID-19 pandemic in India and evaluated the impact of nurse-led teleconsultations on patient treatment satisfaction. DESIGN, SETTING AND PARTICIPANTS: We developed a two-stage teleconsultation strategy and tested the feasibility of implementing a nurse-led teleconsultation strategy to manage CVD in a northern state (Punjab) in India. A multidisciplinary team of experts developed the treatment protocol used for teleconsultations to manage CVD. Nurses were trained to provide teleconsultation, triaging of patients and referrals to the physicians. Patients with CVD who had an outpatient visit or hospitalisation between September 2019 and March 2020 at the Dayanand Medical College Hospital, Ludhiana, India, were contacted by phone and offered teleconsultations. Telemedicine strategy comprised: stage 1 nurse-led teleconsultations and stage 2 physician-led teleconsultations. Descriptive analysis was performed to report the proportion of patients triaged by the two-stage telemedicine strategy, and patient's clinical characteristics, and treatment satisfaction between the nurse-led versus physician-led teleconsultations.Entities:
Keywords: adult cardiology; coronary heart disease; organisation of health services; telemedicine
Mesh:
Year: 2022 PMID: 35798525 PMCID: PMC9263376 DOI: 10.1136/bmjopen-2021-056408
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Figure 1Flow chart of the study design. For hypertension: critically high (SBP ≥160 mm Hg and DBP ≥100 mm Hg), Intermediate high (SBP 130–159 mm Hg and DBP 80–99 mm Hg), controlled (SBP<130 mm Hg and DBP<80 mm Hg). For Diabetes: critically high (RBS ≥300 mg/dL), intermediate high (RBS 200–299 mg/dL), controlled (RBS <200 mg/dL). DBP, diastolic blood pressure; DM, diabetes mellitus; HCWs, healthcare workers; HTN, hypertension; IPD, inpatient department; OPD, outpatient department; RBS, random blood sugar; RT-PCR, reverse transcription PCR; SBP, systolic blood pressure.
Characteristics of study participants during the nurse-led stage-1 teleconsultations
| Total (%) (N=12 042) | |
| Age (in years), mean (SD) | 58.9 (12.8) |
| Men | 7870 (65.4) |
| Hypertension | 5515 (45.8) |
| Diabetes mellitus | 5046 (41.9) |
| Clinical symptoms | |
| 137 (1.1) | |
| 29 (0.2) | |
| 142 (1.2) | |
| 57 (0.5) | |
| 42 (0.3) | |
| 99 (0.8) | |
| 231 (1.9) | |
| Hypertension self-care | |
| 6248 (51.9) | |
| 193 (1.6) | |
| Blood sugar self-care | |
| 3843 (31.9) | |
| 333 (2.8) | |
| Treatment | |
| 11 400 (94.7) | |
| 10 577 (87.8) | |
| 7330 (60.9) | |
| 4656 (38.7) | |
| 5018 (41.7) | |
| ACE inhibitors/ARBs | 3937 (33) |
| Calcium channel blockers | 2419 (20.1) |
| Antiplatelet drugs | 5361 (44.5) |
| Well-being score categories | |
| 161 (1.3) | |
| 1379 (11.5) | |
| 9018 (74.9) | |
| 1482 (12.3) |
*Critically high BP defined as SBP ≥ 160 mm Hg and DBP≥ 100 mm Hg.
†Critically high defined as RBS ≥200 mg/dL.
‡Referred to the adherence to the medication prescribed to the patient.
§Defined if the patient was doing yoga as advised at the time of discharge or at least >30 min of moderate activity for at least five times a week (preferably daily).
ARB, angiotensin receptor blocker; BP, blood pressure; DBP, diastolic BP; RBS, random blood sugar; SBP, systolic BP.
Reasons for patient referrals to the stage-2 physician-led teleconsultations
| Clinical complaints | N=758, N (%) |
| Congestive heart failure | 123 (16.2) |
| Ischaemic heart disease | 51 (6.7) |
| Psychiatric issues | 33 (4.4) |
| Medicinal issues* | 122 (16.1) |
| Uncontrolled hypertension (blood pressure ≥160/100 mm Hg) | 142 (18.7) |
| Uncontrolled diabetes (random blood sugar ≥200 mg/dL) | 189 (24.9) |
| Referred for admission† | 64 (8.4) |
*Issues related alteration of drug dosage, continuation or stoppage of medications, perceived side effects of drugs.
†Reason for admission included diagnostic evaluation and management of acute coronary syndrome or worsening heart failure symptoms.
Impact of COVID-19 pandemic on the patients with cardiovascular diseases
| Overall (N=1090), N (%) | |
| Stress from work or other responsibilities | |
| 6 (0.6) | |
| 49 (4.5) | |
| 80 (7.3) | |
| 955 (87.6) | |
| Ability to cope with stress during the pandemic | |
| 656 (60.2) | |
| 59 (5.4) | |
| 6 (0.6) | |
| 369 (33.9) | |
| Overall health status*, mean (SD) | 88.4±6.8 |
*Health status assessed on a visual analogue scale of 0–100 (0=worst imagined heath status, 100=best imagined health status).
Comparison of patient’s treatment satisfaction between the nurse-led versus physician-led teleconsultations
| Nurse-led teleconsultation n=801 | Physician-led teleconsultation n=289 | Χ2 value | P value | |
| Overall health status*, mean (SD) | 88.8±6.2 | 87.5±8.1 | 0.034 | 0.973 |
| Treatment satisfaction | ||||
| 64 (8%) | 14 (4.8%) | 3.163 | 0.075 | |
| 1012 (92.8%) | 275 (95.2%) |
*Health status assessed on a Visual Analogue Scale of 0–100 (0=worst imagined heath status, 100=best imagined health status).